AUM $18.8MER 0.85%NAV $34.52Holdings 32Inception Jan 2023
Price Chart
Key Statistics
Previous Close
$34.18Day Range
N/A52-Week Range
$26.42$35.45
Avg Volume
2.1KDividend Yield
1.19%Expense Ratio
0.85%AUM
$18.8MShares Outstanding
541.3KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 67.82% |
| Switzerland | 10.81% |
| United Kingdom | 8.99% |
| Other | 7.89% |
| Ireland | 4.50% |
Fund Information
- Issuer
- Horizon Kinetics
- Category
- Healthcare
- Inception Date
- Jan 26, 2023
- Exchange
- NASDAQ
- Description
- The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, aiming to capture returns from intrinsic valuation realization and scientific discovery.
Similar ETFs
The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund issued by Horizon Kinetics that launched on Jan 26, 2023. It currently manages $18.8M in assets under management. The fund charges an expense ratio of 0.85%. The fund holds 32 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 69.8% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 18.41% | 3,077 | $3.5M |
| 2 | ABBV | AbbVie Inc | 8.41% | 7,034 | $1.6M |
| 3 | — | US BANK MMDA - USBGFS 7 06/01/2031 | 7.58% | 1,424,810 | $1.4M |
| 4 | NVS | Novartis AG | 6.94% | 8,791 | $1.3M |
| 5 | JNJ | Johnson & Johnson | 5.34% | 4,401 | $1.0M |
| 6 | AZN | AstraZeneca PLC | 5.08% | 5,256 | $956K |
| 7 | ALKS | Alkermes PLC | 4.87% | 21,099 | $915K |
| 8 | BMY | Bristol-Myers Squibb Co | 4.62% | 15,348 | $869K |
| 9 | IONS | Ionis Pharmaceuticals Inc | 4.56% | 11,428 | $859K |
| 10 | AMGN | Amgen Inc | 3.97% | 2,161 | $747K |
| 11 | MRK | Merck & Co Inc | 3.93% | 6,154 | $740K |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | 3.67% | 2,272 | $690K |
| 13 | PFE | Pfizer Inc | 3.24% | 23,736 | $610K |
| 14 | BIIB | Biogen Inc | 2.98% | 2,857 | $561K |
| 15 | CRSP | CRISPR Therapeutics AG | 2.93% | 9,671 | $551K |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — | |
| 1W | +0.69% | |
| 1M | +4.01% | |
| 3M | +3.88% | |
| 6M | +2.70% | |
| YTD | +4.65% | |
| 1Y | +27.40% | |
| 3Y | +11.33% | |
| 5Y | +11.67% |
Moving Averages
20-Day MA
$33.72
Above 20-Day MA50-Day MA
$33.21
Above 50-Day MA200-Day MA
$32.49
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$35.45
Current Price
$34.46
52-Week Low
$26.42
$26.42$35.45
Current Yield
1.19%
Annual Dividend
$2.5581
Frequency
1x/year
Last Ex-Date
Dec 23, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 23, 2025 | $0.4088 | Dec 24, 2025 |
| Dec 24, 2024 | $0.5071 | Dec 26, 2024 |
| Dec 27, 2023 | $1.6423 | Dec 29, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | MEDX | Healthcare(174 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.85% | 0.60% | 0.66% |
| AUM | $18.8M | $875.8M | $1.45B |
| Dividend Yield | 1.19% | 3.42% | 1.82% |
| Avg Volume | 2.1K | 270.2K | 508.2K |
| Holdings | 32 | 89 | 42 |
| Performance | |||
| 1-Month Return | +5.29% | +2.02% | +2.81% |
| 6-Month Return | +5.99% | +3.84% | +5.39% |
| YTD Return | +4.62% | +3.23% | +4.76% |
| 1-Year Return | +28.20% | +23.91% | +34.52% |
Compare with Another ETF
Search for an ETF to compare with MEDX:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.